Table 1.
Visits and procedures to be performed
| Visit 1 Screening (0 months) | Visit 2 (3 months) | Visit 3 (6 months) | Visit 4 (9 months) | Visit 5 (12 months) | |
|---|---|---|---|---|---|
| Recruitment following the selection criteria | X | ||||
| Informed consent | X | ||||
| Initial collection clinical information and sociodemographic data | X | ||||
| BP control | X | X | X | X | X |
| Lipid profile control | X | X | X | ||
| Counting of drug packages | X | X | X | X | |
| Morisky-Green test | X | X | X | X | X |
| Data collection for errors and adverse effects | X | X | X | X | |
| Collection of followed-up clinical variables | X | X | X | X |